The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/24032
StudyName: Eligibility Peripheral T-Cell Lymphoma NCT01482962 DRKS00004503
Date of export from the portal: 02.07.2020
Date of Upload / last change: 23.07.2017
License: Creative Commons BY 4.0

----

Description: 
Responsible Party: 	Millennium Pharmaceuticals, Inc.
ClinicalTrials.gov Identifier: 	NCT01482962     History of Changes
Other Study ID Numbers: 	C14012
2011-003545-18 ( EudraCT Number )
DRKS00004503 ( Registry Identifier: Germany (DRKS) )
NL39566.068.12 ( Registry Identifier: Netherlands (CCMO) )
U1111-1181-8218 ( Registry Identifier: WHO )
Study First Received: 	November 28, 2011
Last Updated: 	March 30, 2017

Alisertib (MLN8237) or Investigator's Choice in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma
ODM derived from: https://clinicaltrials.gov/ct2/show/NCT01482962
